Treffer 1 - 4 von 4 für Suche 'Bianca Reiskopf', Suchdauer: 0,41s Treffer weiter einschränken
  1. 1
    Bone Specific Alkaline Phosphatase and Serum Calcification Propensity Are Not Influenced by Etelcalcetide vs. Alfacalcidol Treatment, and Only Bone Specific Alkaline Phosphatase Is Correlated With Fibroblast Growth Factor 23: Sub-Analysis Results of the ETACAR-HD Study

    Bone Specific Alkaline Phosphatase and Serum Calcification Propensity Are Not Influenced by Etelcalcetide vs. Alfacalcidol Treatment, and Only Bone Specific Alkaline Phosphatase Is... von Dörr, Katharina, Hödlmoser, Sebastian, Kammer, Michael, Reindl-Schwaighofer, Roman, Lorenz, Matthias, Reiskopf, Bianca, Jagoditsch, Rahel, Marculescu, Rodrig, Oberbauer, Rainer

    Veröffentlicht in Frontiers in medicine

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial

    Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial von Reindl-Schwaighofer, Roman, Heinzel, Andreas, Mayrdorfer, Manuel, Jabbour, Rhea, Hofbauer, Thomas M, Merrelaar, Anne, Eder, Michael, Regele, Florina, Doberer, Konstantin, Spechtl, Paul, Aschauer, Constantin, Koblischke, Maximilian, Paschen, Christopher, Eskandary, Farsad, Hu, Karin, Öhler, Barbara, Bhandal, Arshdeep, Kleibenböck, Sabine, Jagoditsch, Rahel I, Reiskopf, Bianca, Heger, Florian, Bond, Gregor, Böhmig, Georg A, Strassl, Robert, Weseslindtner, Lukas, Indra, Alexander, Aberle, Judith H, Binder, Michael, Oberbauer, Rainer

    Veröffentlicht in JAMA internal medicine

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Cilgavimab and tixagevimab as pre-exposure prophylaxis in vaccine non-responder kidney transplant recipients during a period of prevalent SARS-CoV-2 BA.2 and BA.4/5 variants—a prospective cohort study (RESCUE-TX)

    Cilgavimab and tixagevimab as pre-exposure prophylaxis in vaccine non-responder kidney transplant recipients during a period of prevalent SARS-CoV-2 BA.2 and BA.4/5 variants—a pros... von Reindl-Schwaighofer, Roman, Heinzel, Andreas, Raab, Lukas, Strassl, Robert, Herz, Carsten T., Regele, Florina, Doberer, Konstantin, Helk, Oliver, Spechtl, Paul, Aschauer, Constantin, Hu, Karin, Jagoditsch, Rahel, Reiskopf, Bianca, Böhmig, Georg A., Benka, Bernhard, Mahr, Benedikt, Stiasny, Karin, Weseslindtner, Lukas, Kammer, Michael, Wekerle, Thomas, Oberbauer, Rainer

    Veröffentlicht in EBioMedicine

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  4. 4
    Cilgavimab and tixagevimab as pre-exposure prophylaxis in vaccine non-responder kidney transplant recipients during a period of prevalent SARS-CoV-2 BA.2 and BA.4/5 variants—a prospective cohort study (RESCUE-TX)Research in context

    Cilgavimab and tixagevimab as pre-exposure prophylaxis in vaccine non-responder kidney transplant recipients during a period of prevalent SARS-CoV-2 BA.2 and BA.4/5 variants—a pros... von Roman Reindl-Schwaighofer, Andreas Heinzel, Lukas Raab, Robert Strassl, Carsten T. Herz, Florina Regele, Konstantin Doberer, Oliver Helk, Paul Spechtl, Constantin Aschauer, Karin Hu, Rahel Jagoditsch, Bianca Reiskopf, Georg A. Böhmig, Bernhard Benka, Benedikt Mahr, Karin Stiasny, Lukas Weseslindtner, Michael Kammer, Thomas Wekerle, Rainer Oberbauer

    Veröffentlicht in EBioMedicine

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: